Generation and identification of monoclonal antibodies against FNIII Domain D of human tenascin-C

Hybridoma

Volumn 29, Issue 1, 2010, Pages 13-16

  Wang, Yu Cai ^a   Zheng, Lian He ^a   Ma, Bao An ^a   Zhou, Yong ^a   Fan, Qing Yu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; TENASCIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL SECRETION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC CODE; HYBRIDOMA CELL CULTURE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BONE NEOPLASMS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; HUMANS; IMMUNIZATION; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; OSTEOSARCOMA; PEPTIDE FRAGMENTS; TENASCIN; TUMOR CELLS, CULTURED;

MURINAE;

EID: 77749246193     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2009.0059     Document Type: Article

References (14)

1. Liakka KA, and Autio-Harmainen HI: Distribution of the extracellular matrix proteins tenascin, fibronectin, and vitronectin in fetal, infant, and adult human spleens. J His-tochem Cytochem 1992;40:1203-1210.
2. Hamilton DW: Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2008;2:9-17.
3. Päiväniemi OE, Maasilta PK, Alho HS, Vainikka TL, and Salminen US: Epithelial tenascin predicts obliterative airway disease. J Heart Lung Transplant 2008;27:400-407.
4. Chen J, Chen Z, Chen M, Li D, Li Z, Xiong Y, Dong J, and Li X: Role of fibrillar Tenascin-C in metastatic pancreatic cancer. Int J Oncol 2009;34:1029-1036.
5. Gulcher JR, Nies DE, Alexakos MJ, Ravikant NA, Sturgill ME, Marton LS, and Stefansson K: Structure of the human hexabrachion (tenascin) gene. Proc Natl Acad Sci USA 1991;88:9438-9442.
6. Hsia HC, and Schwarzbauer JE: Meet the tenascins: multifunctional and mysterious. J Biol Chem 2005;280: 26641-26644.
7. de Alava E: Molecular pathology in sarcomas. Clin Trans Oncol 2007;9:130-144.
8. Tanaka M, Yamazaki T, Araki N, Yoshikawa H, Yoshida T, Sakakura T, and Uchida A: Clinical significance of tenascin-C expression in osteosarcoma: tenascin-C promotes distant metastases of osteosarcoma. Int J Mol Med 2000;5:505-510.
9. Feng X, Xu R, Gao Y, He Z, Li C, and Wang H: Generation and identification of natural monoclonal antibodies against low-density lipoprotein. Hybridoma 2008;27:54-58.
10. Gentili C, and Cancedda R: Cartilage and bone extracellular matrix. Curr Pharm Des 2009;15:1334-1348.
11. Chiquet-Ehrismann R, and Tucker RP: Connective tissues: signalling by tenascins. Int J Biochem Cell Biol 2004;36: 1085-1089.
12. Hasegawa M, Nakoshi Y, Muraki M, Sudo A, Kinoshita N, Yoshida T, and Uchida A: Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res 2007;25:563-568.
13. El-Karef A, Kaito M, Tanaka H, Ikeda K, Nishioka T, Fujita N, Inada H, Adachi Y, Kawada N, Nakajima Y, Imanaka-Yoshida K, and Yoshida T: Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. J Hepatol 2007;46:664-673.
14. Chapados R, Abe K, Ihida-Stansbury K, McKean D, Gates AT, Kern M, Merklinger S, Elliott J, Plant A, Shimokawa H, and Jones PL: ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling. Circ Res 2006;99:837-844.